State Of Wisconsin Investment Board Compugen LTD Transaction History

State Of Wisconsin Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.57 - $3.33 $29,172 - $61,874	-18,581 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.09 - $7.16 $16,834 - $29,470	4,116 Added 28.45%	18,581 $80,000
Q3 2021 Nov 12, 2021	SELL	$5.8 - $8.02 $19,343 - $26,746	-3,335 Reduced 18.74%	14,465 $86,000
Q2 2021 Aug 12, 2021	SELL	$6.87 - $9.16 $19,627 - $26,170	-2,857 Reduced 13.83%	17,800 $147,000
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $28,885 - $51,857	3,766 Added 22.3%	20,657 $177,000

Q4 2020 Feb 03, 2021	SELL	$12.07 - $17.95 $71,176 - $105,851	-5,897 Reduced 25.88%	16,891 $205,000
Q3 2020 Nov 16, 2020	BUY	$14.16 - $19.45 $127,326 - $174,894	8,992 Added 65.18%	22,788 $370,000
Q2 2020 Aug 12, 2020	BUY	$6.97 - $17.12 $96,158 - $236,187	13,796 New	13,796 $207,000

13.7M

131K

76K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $146M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.